Grant I. (2015). Medical Use of Cannabinoids. JAMA. 2015 Oct 27;314(16):1750-1. doi: 10.1001/jama.2015.11429.
Wallace MS, Marcotte TD, Umlauf A, Gouaux B, Atkinson JH. (2015). Efficacy of Inhaled Cannabis on Painful Diabetic Neuropathy. J Pain. 2015 Apr 2. pii: S1526-5900(15)00601-X. doi: 10.1016/j.jpain.2015.03.008. [Epub ahead of print]
Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H. (2013). Low-Dose Vaporized Cannabis Significantly Improves Neuropathic Pain. J Pain, 14(2):136-48.
Grant I, Atkinson JH, Gouaux B. (2012). Research on medical marijuana. Am J Psychiatry, 169(10):1119-20. DOI: 10.1176/appi.ajp.2012.12060791.
Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte T, Bentley H, Gouaux B. (2012). Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. CMAJ, 184 (10):1143-50.
Grant I, Atkinson JH, Gouaux B, Wilsey B. (2012). Medical Marijuana: Clearing Away the Smoke. The Open Neurology Journal. 2012 May 4, 6:18-25. DOI: 10.2174/1874205X01206010018.
Riggs PK, Vaida F, Rossi SR, Sorkin LS, Gouaux B, Grant I, Ellis RJ. (2011). A pilot study of the effects of cannabis on appetite hormones in HIV-infected adult men. Brain Research. 2012 Jan 11;1431:46-52. Epub 2011 Nov 7.
Ellis RJ, Toperoff W, Vaida F, van den Brande G, Gonzales J, Gouaux B, Bentley H, Atkinson JH. (2009). Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial. Neuropsychopharmacology, 34(3), 672-80.
Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte T, Bentley H, Gouaux B. Short-Term Effects of Medicinal Cannabis on Spasticity in Multiple Sclerosis. Poster presented at the 60th Annual Meeting of the American Academy of Neurology (Chicago, IL). 2008.
Wilsey B, Marcotte T, Tsodikov A, Millman J, Bentley H, Gouaux B, Fishman S. (2008) A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain. J Pain, 9(6):506-21.
Wallace M, Schulteis G, Atkinson JH, Wolfson T, Lazzaretto D, Bentley H, Gouaux B, Abramson I (November 2007) Dose-dependent Effects of Smoked Cannabis on Capsaicin-induced Pain and Hyperalgesia in Healthy Volunteers. Anesthesiology. 107(5):785-796
Gonzalez R, Martin EM, Grant I, Neuropsychology and Substance Use, Taylor & Francis Group. (2007) Marijuana (Chapter 5, 139-170)
Abrams DI, Vizoso HP, hade SB, Jay C, Kelly ME, and Benowitz NL. (2007). Vaporization as a Smokeless Cannabis Delivery System: A Pilot Study. Clin Pharmacol Ther, 82(5):572-8.
Abrams DI, Jay CA, Shade SB, Vizoso H, Reda H, Press S, Kelly ME, Rowbotham MC, Petersen KL. Cannabis in painful HIV-associated sensory neuropathy: A randomized placebo-controlled trial. Neurology 2007 68: 515-521.
Rossi S, Yaksh T, Bentley H, van den Brande G, Grant I, Ellis R. (2006). Characterization of interference with 6 commercial delta9-tetrahydrocannabinol immunoassays by efavirenz (glucuronide) in urine. Clinical Chemistry, 52, 896-7.
Igor Grant and B. Rael Cahn, Cannabis and endocannabinoid modulators: Therapeutic promises and challenges, Clinical Neuroscience Research, Volume 5, Issues 2-4, November 2005, Pages 185-199.
Abrams, D., Jay, C., Vizoso, H., Shade, S., Reda, H., Press, S., Kelley, M.E., Rowbotham, M., Petersen, K. Smoked Cannabis Therapy for HIV-Related Painful Peripheral Neuropathy: Results of a Randomized, Placebo-Controlled Clinical Trial. 2nd Annual Meeting of the International Association for Cannabis as Medicine. 2005.
Ilan, A., Gevins, A., Role, K., Vizoso, H., Abrams, D. The Cognitive Neurophysiological Effects of Medicinal Marijuana in HIV+ Patients with Peripheral Neuropathy. 2nd Annual Meeting of the International Association for Cannabis as Medicine. 2005.
Abrams, D., Vizoso, H., Shade, S., Jay, C., Kelley, M.E., Benowitz, N. Vaporization as a Smokeless Cannabis Delivery System: A Pilot Study. 2nd Annual Meeting of the International Association for Cannabis as Medicine. 2005.
Marcotte, T., Rosenthal, T., Corey-Bloom, J., Roberts, E., Lampinen, S., Allen, W. The Impact of Cognitive Deficits and Spasticity on Driving Simulator Performance in Multiple Sclerosis. Proceedings of the Third International Driving Symposium on Human Factors in Driver Assessment, Training, and Vehicle Design. 2005.
Lopez, C., Toperoff, W., van den Brande, G., Tapert, S., Atkinson, J.H., Drummond, S.P.A., Increased Sleep Disturbances in Patients with HIV-Related Neuropathy. 2005 Annual Meeting of the Associated Professional Sleep Societies.
Igor Grant, Foreword by Igor Grant, M.D., Director, Center for Medicinal Cannabis Research (CMCR), Neuropharmacology, Volume 48, Issue 8, June 2005, Page 1067.
Alexandros Makriyannis, Raphael Mechoulam and Daniele Piomelli, Therapeutic opportunities through modulation of the endocannabinoid system, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1068-1071.
Cecilia J. Hillard and Abbas Jarrahian, Accumulation of anandamide: Evidence for cellular diversity, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1072-1078.
Natsuo Ueda, Kazuhito Tsuboi and Didier M. Lambert, A second N-acylethanolamine hydrolase in mammalian tissues, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1079-1085.
Shou-Yuan Zhuang, Daniel Bridges, Elena Grigorenko, Stephen McCloud, Andrew Boon, Robert E. Hampson and Sam A. Deadwyler, Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1086-1096.
Liana Fattore, Sabrina Spano, Gregorio Cossu, Serena Deiana, Paola Fadda and Walter Fratta, Cannabinoid CB1 antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1097-1104.
Carl R. Lupica and Arthur C. Riegel, Endocannabinoid release from midbrain dopamine neurons: a potential substrate for cannabinoid receptor antagonist treatment of addiction, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1105-1116.
Ester Fride, Datta Ponde, Aviva Breuer and Lumir Hanus, Peripheral, but not central effects of cannabidiol derivatives: Mediation by CB1 and unidentified receptors, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1117-1129.
Pàl Pacher, Sàndor Bàtkai and George Kunos, Blood pressure regulation by endocannabinoids and their receptors, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1130-1138.
Roger G. Pertwee, Adèle Thomas, Lesley A. Stevenson, Yehoshua Maor and Raphael Mechoulam, Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB1, non-CB2, non-TRPV1 target in the mouse vas deferens, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1139-1146.
Jin Fu, Fariba Oveisi, Silvana Gaetani, Edward Lin and Daniele Piomelli, Oleoylethanolamide, an endogenous PPAR-[alpha] agonist, lowers body weight and hyperlipidemia in obese rats, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1147-1153.
Nissar A. Darmani, Angelo A. Izzo, Brian Degenhardt, Marta Valenti, Giuseppe Scaglione, Raffaele Capasso, Italo Sorrentini and Vincenzo Di Marzo, Involvement of the cannabimimetic compound, N-palmitoyl-ethanolamine, in inflammatory and neuropathic conditions: Review of the available pre-clinical data, and first human studies, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1154-1163.
Kahlid Salim, Udo Schneider, Sumner Burstein, Ludwig Hoy and Matthias Karst, Pain measurements and side effect profile of the novel cannabinoid ajulemic acid, Neuropharmacology, Volume 48, Issue 8, June 2005, Pages 1164-1171.
de Jong, B.C., Prentiss, D., McFarland, W., Machekano, R., and Israelski, D.M. (2005) Marijuana use and its association with adherence to antiretroviral therapy among HIV-infected persons with moderate to severe nausea. Journal of Acquired Immune Deficiency Syndrome, 38, (1), 43-46.
Giuffrida A, Leweke FM, Gerth CW, Schreiber D, Koethe D, Faulhaber J, Klosterkotter J, Piomelli D. Cerebrospinal Anandamide Levels are Elevated in Acute Schizophrenia and are Inversely Correlated with Psychotic Symptoms. Neuropsychopharmacology. 2004 Nov;29(11):2108-14.
Schrier, R., Soto, P., Hamlat, C., Durand, D., Ceci, K., Ellis, R. (2004, 3). Effects of in Vitro Cannabinoids on T-cell Responses of HIV Infected Patients. Poster presented at the 10th Society on Neuroimmune Pharmacology Conference (Santa Fe, NM).
Jay, C., Shade, S., Vizoso, H., Reda, H., Petersen, K., Rowbotham, M., Abrams, D. The Effect of Smoked Marijuana on Chronic Neuropathic and Experimentally-Induced Pain in HIV Neuropathy: Results of an Open-Label Pilot Study. Proceedings 11th Conference on Retroviruses and Opportunistic Infections, abstract 496, p.243, 2004.
A.M. Papanastassiou, H.L. Fields, I.D. Meng. Local application of the cannabinoid receptor agonist, WIN 55,212-2, to spinal trigeminal nucleus caudalis differentially affects nociceptive and non-nociceptive neurons.. Pain. 2004 Feb;107(3):267-75.
Diane Prentiss, MA, MPH, Rachel Power, PhD, Gladys Balmas MD, MPH, Gloria Tzuang, MPH, and Dennis M. Israelski, MD. Patterns of Marijuana Use Among Patients With HIV/AIDS Followed in a Public Health Care Setting. JAIDS Volume 35, Number 1, January 1, 2004
Abrams, D.I., Jay, C., Petersen, K., Shade, S., Vizoso, H., Reda, H., Benowitz, N., Rowbotham, M. The Effects of Smoked Cannabis in Painful Peripheral Neuropathy and Cancer Pain Refractory to Opioids. Proceedings of the International Association of Cannabis as Medicine, Cologne, 2003, p.28.
Grant, I., Gonzalez, R., Carey, C., Natarajan, L., and Wolfson, T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: A meta-analysis study. Journal of the International Neuropsychological Society, 9, 679-689.
Gonzalez R., Carey, C., and Grant, I.: Nonacute (Residual) Neuropsychological Effects of Cannabis Use: A Qualitative Analysis and Systemic Review. J Clin Pharmacol 2002: 42; 48S-57S.